References
Wanchoo R, Abudayyeh A, Doshi M et al (2017) Renal toxicities of novel agents used for treatment of multiple myeloma. Clin J Am Soc Nephrol 12(1):176–189
Glezerman IG, Kewalramani T, Jhaveri K (2008) Reversible Fanconi syndrome due to lenalidomide. NDT Plus 1(4):215–217
Wesner N, Bihan K, Cez A et al (2019) Two cases of reversible Fanconi syndrome induced by lenalidomide. Leuk Lymphoma 60(4):1092–1094
Funding
This manuscript did not receive any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare. This case report was exempted from local institutional review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lim, C.C., Lwin, K.Z.L., Cheong, M.A. et al. An unusual cause of renal tubular dysfunction in multiple myeloma. Int Urol Nephrol 52, 1603–1605 (2020). https://doi.org/10.1007/s11255-020-02504-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02504-z